Enovix Co. (NASDAQ:ENVX) Receives $17.27 Consensus PT from Analysts

Enovix Co. (NASDAQ:ENVXGet Free Report) has earned a consensus recommendation of “Moderate Buy” from the eleven research firms that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $17.27.

A number of research analysts recently weighed in on ENVX shares. B. Riley decreased their target price on shares of Enovix from $17.00 to $12.00 and set a “buy” rating for the company in a research report on Tuesday, April 29th. Benchmark dropped their target price on Enovix from $25.00 to $15.00 and set a “buy” rating on the stock in a report on Tuesday, April 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $30.00 price target on shares of Enovix in a research report on Thursday, February 20th. JPMorgan Chase & Co. cut their price objective on Enovix from $10.00 to $9.00 and set an “overweight” rating for the company in a report on Thursday, May 1st. Finally, Craig Hallum lowered their target price on shares of Enovix from $20.00 to $18.00 and set a “buy” rating on the stock in a report on Thursday, February 20th.

Check Out Our Latest Analysis on ENVX

Enovix Stock Up 1.7 %

Enovix stock opened at $6.59 on Tuesday. Enovix has a twelve month low of $5.27 and a twelve month high of $18.68. The company has a quick ratio of 3.61, a current ratio of 3.77 and a debt-to-equity ratio of 0.99. The company has a 50 day moving average of $6.98 and a 200-day moving average of $9.16. The stock has a market capitalization of $1.27 billion, a PE ratio of -4.54 and a beta of 1.99.

Enovix (NASDAQ:ENVXGet Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported ($0.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.01. The firm had revenue of $9.72 million for the quarter, compared to the consensus estimate of $8.77 million. Enovix had a negative return on equity of 96.99% and a negative net margin of 963.17%. On average, equities research analysts anticipate that Enovix will post -1.01 EPS for the current fiscal year.

Insider Activity at Enovix

In other Enovix news, CEO Rajendra K. Talluri sold 300,000 shares of the business’s stock in a transaction dated Thursday, February 27th. The shares were sold at an average price of $9.35, for a total value of $2,805,000.00. Following the completion of the sale, the chief executive officer now owns 2,045,301 shares of the company’s stock, valued at $19,123,564.35. The trade was a 12.79 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 15.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Enovix

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Barclays PLC lifted its position in shares of Enovix by 376.9% during the 3rd quarter. Barclays PLC now owns 252,012 shares of the company’s stock valued at $2,353,000 after acquiring an additional 199,166 shares during the period. Virtu Financial LLC acquired a new stake in Enovix during the third quarter worth about $205,000. Franklin Resources Inc. raised its position in shares of Enovix by 81.4% in the 3rd quarter. Franklin Resources Inc. now owns 79,559 shares of the company’s stock valued at $743,000 after buying an additional 35,711 shares in the last quarter. B. Riley Wealth Advisors Inc. bought a new stake in shares of Enovix during the 3rd quarter worth approximately $117,000. Finally, Lpwm LLC acquired a new stake in shares of Enovix during the 4th quarter worth approximately $549,000. 50.92% of the stock is currently owned by institutional investors and hedge funds.

Enovix Company Profile

(Get Free Report

Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Read More

Analyst Recommendations for Enovix (NASDAQ:ENVX)

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.